Client News
Rentschler Biopharma’s ATMP facility in Stevenage, UK, receives MHRA approval
13th September 2023
Mainz Biomed’s ColoFuture Study, Evaluating its Novel mRNA Biomarkers, Reports Groundbreaking Topline Results Demonstrating Sensitivity for Colorectal Cancer of 94% with Specificity of 97% and Advanced Adenoma Sensitivity of 81%
13th September 2023
InflaRx Announces Positive Topline Results from the Single Ascending Dose (SAD) Phase I Study with C5aR Inhibitor INF904
11th September 2023
Adrenomed presents new findings on its precision medicine treatment for septic shock with enibarcimab during Weimar Sepsis Update
8th September 2023
AdhereTech Appoints Innes Meldrum as President and Chief Executive Officer
6th September 2023
Proteros biostructures and Orion Pharma agree on a long-term multi-target collaboration including the assembly of a joint novel and unique HTS small-molecule screening library with the full chemistry support of Enamine
6th September 2023
Element Materials unveils fully integrated pharma services platform, strengthening its expanding Life Sciences Division
5th September 2023
invIOs starts further clinical trial of APN401, novel cell therapy against solid cancers, and secures major Austrian grant funding
5th September 2023
Mainz Biomed Announces Strategic Partnership with Ärztliches Labor Dr. Buhlmann, Expanding Footprint in German Market
5th September 2023
There is no more content to load